Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "US Celiac Disease Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
The report provides comprehensive insights into Celiac Disease pipeline products, Celiac Disease epidemiology, Celiac Disease market valuations and forecast, Celiac Disease drugs sales and competitive landscape in the US.
The research is classified into seven sections - Celiac Disease treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Research Scope
- Celiac Disease pipeline: Find out the products in clinical trials for the treatment of Celiac Disease by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Celiac Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Celiac Disease in the US
- Celiac Disease drugs: Identify key products marketed and prescribed for Celiac Disease in the US, including trade name, molecule name, and company
- Celiac Disease drugs sales: Find out the sales revenues of Celiac Disease drugs in the US
- Celiac Disease market valuations: Find out the market size for Celiac Disease drugs in 2019 in the US. Find out how the market advanced from 2016 and forecast to 2025
- Celiac Disease drugs market share: Find out the market shares for key Celiac Disease drugs in the US
Benefits of this Research
- Support monitoring and reporting national Celiac Disease market analysis and sales trends
- Track competitor drugs sales and market share in the US Celiac Disease market
- Track competitive developments in Celiac Disease market and present key issues and learnings
- Synthesize insights for Celiac Disease market and products to drive business performance
- Answer key business questions about the Celiac Disease market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Celiac Disease products
- Supports decision making in R&D to long term marketing strategies
Key Topics Covered
1) Celiac Disease Treatments
2) Celiac Disease Pipeline
3) US Celiac Disease Epidemiology
4) Marketed Drugs for Celiac Disease in US
5) US Celiac Disease Market Size and Forecast
6) US Celiac Disease Products Sales and Forecast
7) US Celiac Disease Market Competitive Landscape
8) Methodology
List of Tables
1. Celiac Disease Phase 3 Clinical Trials, 2020
2. Celiac Disease Phase 2 Clinical Trials, 2020
3. Celiac Disease Phase 1 Clinical Trials, 2020
4. Celiac Disease Epidemiology, US, 2016-2025
5. Marketed Drugs for Celiac Disease, US, 2019
6. Celiac Disease Market Size and Forecast ($), US, 2016-2025
7. Celiac Disease Product Sales ($), US, 2016-2025
List of Figures
1. Celiac Disease Epidemiology, US, 2016-2025
2. Celiac Disease Market Size and Forecast ($), US, 2016-2025
3. Celiac Disease Products Market Share (%), US, 2019
For more information about this report visit https://www.researchandmarkets.com/r/wjndp6
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.